03 مايو #Docetaxel #Metastatic Prostate Cancer #review Docetaxel Re-challenge in Patients with Metastatic Prostate Cancer: A Comprehensive Review by Dr. Fadi Farhat 0
15 أبريل #adjuvant #Docetaxel #Early-Stage Breast Cancer #Prospective #Real-Life #Toxicity Toxicities Associated with Docetaxel-Based Regimens in the Adjuvant Treatment of Early-Stage Breast Cancer: A Multicenter Prospective Real-Life Experience by Dr. Fadi Farhat 0
17 أغسطس #castration-resistant #Celecoxib #Docetaxel #Phase II #prostate cancer #trial #weekly #Zoledronic acid Phase II trial of weekly Docetaxel, Zoledronic acid, and Celecoxib for castration-resistant prostate cancer by Dr. Fadi Farhat 0
17 يناير #calcitriol #castration-resistant prostate cancer #Docetaxel #High-dose #Phase II #study #zolandronic acid High-dose calcitriol, docetaxel and zoledronic acid in patients with castration-resistant prostate cancer: a phase II study by Dr. Fadi Farhat 0
14 ديسمبر #capecitabine #navelbine #randomized A phase II randomized study comparing navelbine and capecitabine (Navcap) followed either by Navcap or by weekly docetaxel in the first-line treatment of HER-2/neu negative metastatic breast cancer by Dr. Fadi Farhat 0
21 يونيو #advanced #breast cancer #capecitabine #Docetaxel #long-term #Phase II #pilot #sequential #trial #vinorelbine Sequential vinorelbine-capecitabine followed by docetaxel in advanced breast cancer: long-term results of a pilot phase II trial. by Dr. Fadi Farhat 0
23 فبراير #Cancer #Docetaxel #estramustine #hormone #HRPC #prostate #refractory #weekly #zolendronic acid Weekly docetaxel, zoledronic acid and estramustine in hormone-refractory prostate cancer (HRPC) by Dr. Fadi Farhat 0
14 يناير #advanced #Chemotherapy #Docetaxel #first-line #irinotecan #NSCLC #patients #pilot #study Docetaxel and irinotecan as first-line chemotherapy in patients with advanced non-small-cell lung cancer: a pilot study by Dr. Fadi Farhat 0
